Home » Johnson & Johnson Buys 18 Percent Stake in Crucell
Johnson & Johnson Buys 18 Percent Stake in Crucell
U.S. health care products maker Johnson & Johnson Inc. has bought an 18 percent stake in Dutch biotechnology company Crucell NV for euro301.8 million ($440 million) in hopes to develop a universal flu vaccine, the companies said.
denverpost
denverpost
Upcoming Events
-
07May
-
14May
-
30May